Form 4: Moderna President Stephen Hoge Reports Stock Transactions

Stephen Hoge, President of Moderna, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Summary

• On May 28, 2024, Stephen Hoge, President of Moderna, had 610 restricted stock units (RSUs) vest, which converted into common stock on a one-for-one basis.
• To cover tax withholding obligations related to the vesting of these RSUs, Hoge sold 341 shares of common stock on May 29, 2024, at a price of $144.5047 per share.
• Following these transactions, Hoge directly owns 1,471,777 shares of Moderna common stock.
• He also indirectly owns 4,116 shares through Valhalla, LLC and 151,933 shares through a trust for the benefit of his spouse and children.
• Hoge disclaims beneficial ownership of the shares held in the trust, except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider trading activity.

Industry Context

This Form 4 filing is a routine disclosure of stock transactions by a company insider, which is common for publicly traded companies. It provides transparency into the trading activities of key personnel and their holdings in the company.

Comparison to Industry Standards

• Form 4 filings are standard practice for corporate insiders at publicly traded companies like Moderna, similar to filings made by executives at Pfizer, BioNTech, and other pharmaceutical companies.
• The 'sell to cover' transaction for tax obligations is a common mechanism used by companies and executives to manage equity compensation, aligning with industry norms.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the sale of shares, but the overall impact is likely minimal as it is related to tax obligations.

Key Dates